Related Experiment Video

Updated: Jun 19, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Cost implications of new evidence on prevention of cardiovascular disease

Robert C Kaplan1, Clyde Schechter

  • 1Department of Epidemiology and Population Health, Belfer Building, Room 1303A, Albert Einstein, College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA. rkaplan@aecom.yu.edu

Expert Review of Pharmacoeconomics & Outcomes Research
|October 8, 2009
PubMed

Insights

Preventing cardiovascular diseases (CVDs) is crucial for healthcare economies. This review examines cost-effective interventions for managing hypertension, high-risk patients, and smoking cessation, alongside new diagnostic tools.

Area of Science:

  • Health Economics
  • Cardiovascular Medicine
  • Preventive Cardiology

Background:

  • Cardiovascular diseases (CVDs) impose significant burdens on healthcare systems globally.
  • Effective preventive strategies are essential for economic sustainability in healthcare.
  • Understanding the cost-effectiveness of interventions is key to optimizing CVD management.

Purpose of the Study:

  • To review the cost implications of new evidence for cardiovascular disease risk factor treatment.
  • To evaluate the economic efficiency of various preventive interventions for CVDs.

Main Methods:

  • Literature review focusing on cost-effectiveness of CVD preventive interventions.
  • Analysis of recent data on hypertension management, high-risk patient treatment, and smoking cessation.
  • Discussion of emerging screening and diagnostic tools.

Main Results:

  • Low-dose diuretics are the most cost-effective first-line therapy for hypertension.
  • Aggressive antihypertensive and lipid-lowering therapies are supported for high-risk patients, including those with myocardial infarction and diabetes.
  • Behavioral and pharmacologic smoking cessation interventions show promise.

Conclusions:

  • Optimizing cardiovascular disease prevention through cost-effective interventions is vital for healthcare economies.
  • Integrating evidence-based therapies and emerging diagnostics can improve patient outcomes and economic efficiency.
  • Continued evaluation of cost-effectiveness is necessary for evolving CVD management strategies.

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...